VERU
Veru Inc. - Common Stock (VERU)
$44
About Veru Inc. - Common Stock (VERU)
Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$7.33
52 Week Low
$2.05
Market cap
41.1M
Dividend yield
-
Volume
309
Avg. volume
225,811
P/E ratio
-3.94
Veru Inc. - Common Stock News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$7.33
52 Week Low
$2.05
Market cap
41.1M
Dividend yield
-
Volume
309
Avg. volume
225,811
P/E ratio
-3.94